Bo Zhao
- Neurology top 0.5%
- Oncology top 1%
- COVID-19 and healthcare impacts 5
- Epidemiology top 1%
- Gastroenterology top 5%
- Nephrology top 10%
- Dialysis and Renal Disease Management 5
-
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 5
- Metastasis and carcinoma case studies 4
- Tracheal and airway disorders 4
-
- Healthcare Policy and Management 5
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Ya‐Chen Tina ShihShouhao ZhouChan ShenJames C. YaoArvind DasariDaniel M. HalperinYing XuWolfgang C. Winkelmayer
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Bo Zhao
68 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Neurology 1.4k
- Oncology 2.3k
- Epidemiology 2.3k
- Gastroenterology 140
- Nephrology 86
Countries citing papers authored by Bo Zhao
This map shows the geographic impact of Bo Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhao more than expected).
Fields of papers citing papers by Bo Zhao
This network shows the impact of papers produced by Bo Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhao. The network helps show where Bo Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 18 | |
| 16 | 2020 | 42 | |
| 17 | 2020 | 74 | |
| 18 | 2019 | 4 | |
| 19 | 2018 | 42 | |
| 20 | 2017 | 17 |
About Bo Zhao
Bo Zhao is a scholar working on Family Practice, Nephrology and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 3.2k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (5 papers), COVID-19 and healthcare impacts (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Healthcare Policy and Management (5 papers), Metastasis and carcinoma case studies (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Tracheal and airway disorders (4 papers). The work is most often cited by research in Neurology (1.4k citations), Oncology (2.3k citations) and Epidemiology (2.3k citations). Bo Zhao has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Ya‐Chen Tina Shih, Shouhao Zhou, Chan Shen, James C. Yao, Arvind Dasari, Daniel M. Halperin, Ying Xu, Wolfgang C. Winkelmayer, Kevin F. Erickson and Yunman Li. Their work appears in journals such as Journal of Clinical Oncology, Water Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.